- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
O
OGEN
Oragenics
0.69
0.00-0.14%After Hours: 0.6892 0.00 0.00%19:43 02/20 EST
OPEN/PREV CLOSE0.6770/0.6902
TODAY RANGE0.6602-0.6892
VOL19.72K
MARKET CAP2.87M
52 WEEK RANGE0.6111-9.60
AVG VOL (3M)359.35K
% TURNOVER0.47%
TURNOVER--
P/E (TTM)-0.0402
% RANGE4.03%
EPS(TTM)-17.1532
P/E(FORWARD)-0.9068
P/B0.2893
BVPS2.382
DIVIDEND--
P/S68.12
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.80M
SHARES OUTSTANDING4.17M
NEXT EARNINGS03/12-03/16
FREE FLOAT4.07M
LOT SIZE1
EX-DATE06/03/2025
News
Press Releases
Financial Reports
Profile
TipRanks·02/09 13:46
Oragenics previews targeted milestones for 2026
TipRanks·02/03 13:40
Oragenics partners with Duck Flats Pharma to support FDA IND trial design
Benzinga·01/28 21:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
TipRanks·01/22 21:36
Oragenics Extends At-the-Market Equity Sales Agreement
TipRanks·01/22 21:15
Oragenics files $100M mixed securities shelf
Benzinga·01/22 09:46
Why High Roller Technologies Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
TipRanks·12/15/2025 21:38
Oragenics Adjusts Executive Compensation Plan
Benzinga·11/12/2025 13:38
Reported November 7, 2025: Oragenics Q3 EPS $(1.96) Up From $(11.32) YoY
TipRanks·10/21/2025 12:17
Oragenics Regains NYSE Compliance After Public Offering
TipRanks·10/21/2025 12:15
Oragenics regains compliance with NYSE
Benzinga·10/21/2025 12:01
Oragenics Regains Nasdaq Compliance
Dow Jones·10/21/2025 12:00
*Oragenics Regains Full NYSE Compliance, Resolves Stockholder Equity Deficiency
Same Industry
Name/Symbol
Change%
Price